10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
UNITEDHEALTH GROUP INC | |||
Ticker: UNH Fiscal Year: 2020 | |||
Consolidated Statements of Operations | |||
Period Ending Dec 31, 2020 10-K (Filed: Mar 1, 2021) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
| Revenues: | |||
| Premiums | $ 201,478 | 189,699 | 178,087 |
| Products | 34,145 | 31,597 | 29,601 |
| Services | 20,016 | 18,973 | 17,183 |
| Investment and other income | 1,502 | 1,886 | 1,376 |
| Total revenues | 257,141 | 242,155 | 226,247 |
| Operating costs: | |||
| Medical costs | 159,396 | 156,440 | 145,403 |
| Operating costs | 41,704 | 35,193 | 34,074 |
| Cost of products sold | 30,745 | 28,117 | 26,998 |
| Depreciation and amortization | 2,891 | 2,720 | 2,428 |
| Total operating costs | 234,736 | 222,470 | 208,903 |
| Earnings from operations | 22,405 | 19,685 | 17,344 |
| Interest expense | (1,663) | (1,704) | (1,400) |
| Earnings before income taxes | 20,742 | 17,981 | 15,944 |
| Provision for income taxes | (4,973) | (3,742) | (3,562) |
| Net earnings | 15,769 | 14,239 | 12,382 |
| Earnings attributable to noncontrolling interests | (366) | (400) | (396) |
| Net earnings attributable to UnitedHealth Group common shareholders | 15,403 | 13,839 | 11,986 |
| Earnings per share attributable to UnitedHealth Group common shareholders: | |||
| Basic | 16.23 | 14.55 | 12.45 |
| Diluted | 16.03 | 14.33 | 12.19 |
| Basic weighted-average number of common shares outstanding | 949 | 951 | 963 |
| Dilutive effect of common share equivalents | 12 | 15 | 20 |
| Diluted weighted-average number of common shares outstanding | 961 | 966 | 983 |
| Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents | 8 | 10 | 6 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
UNITEDHEALTH GROUP INC | |||
Ticker: UNH Fiscal Year: 2020 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2020 10-K (Filed: Mar 1, 2021) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
| Net earnings | $ 15,769 | 14,239 | 12,382 |
| Other comprehensive (loss) income: | |||
| Gross unrealized gains (losses) on investment securities during the period | 1,058 | 1,212 | (294) |
| Income tax effect | (253) | (279) | 67 |
| Total unrealized gains (losses), net of tax | 805 | 933 | (227) |
| Gross reclassification adjustment for net realized gains included in net earnings | (75) | (104) | (62) |
| Income tax effect | 17 | 24 | 14 |
| Total reclassification adjustment, net of tax | (58) | (80) | (48) |
| Total foreign currency translation losses | (983) | (271) | (1,242) |
| Other comprehensive (loss) income | (236) | 582 | (1,517) |
| Comprehensive income | 15,533 | 14,821 | 10,865 |
| Comprehensive income attributable to noncontrolling interests | (366) | (400) | (396) |
| Comprehensive income attributable to UnitedHealth Group common shareholders | 15,167 | 14,421 | 10,469 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
UNITEDHEALTH GROUP INC | |||
Ticker: UNH Fiscal Year: 2020 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2020 10-K (Filed: Mar 1, 2021) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
| Operating activities | |||
| Net earnings | $ 15,769 | 14,239 | 12,382 |
| Noncash items: | |||
| Depreciation and amortization | 2,891 | 2,720 | 2,428 |
| Deferred income taxes | (8) | 230 | 42 |
| Share-based compensation | 679 | 697 | 638 |
| Other, net | (52) | (106) | (71) |
| Net change in other operating items, net of effects from acquisitions and changes in AARP balances: | |||
| Accounts receivable | (688) | 162 | (1,351) |
| Other assets | (2,195) | (1,563) | (750) |
| Medical costs payable | 152 | 1,221 | 1,831 |
| Accounts payable and other liabilities | 5,348 | 733 | 526 |
| Unearned revenues | 278 | 130 | 38 |
| Cash flows from operating activities | 22,174 | 18,463 | 15,713 |
| Investing activities | |||
| Purchases of investments | (16,577) | (18,131) | (14,010) |
| Sales of investments | 6,489 | 8,536 | 3,641 |
| Maturities of investments | 7,252 | 7,091 | 6,270 |
| Cash paid for acquisitions, net of cash assumed | (7,139) | (8,343) | (5,997) |
| Purchases of property, equipment and capitalized software | (2,051) | (2,071) | (2,063) |
| Other, net | (506) | 219 | (226) |
| Cash flows used for investing activities | (12,532) | (12,699) | (12,385) |
| Financing activities | |||
| Common share repurchases | (4,250) | (5,500) | (4,500) |
| Cash dividends paid | (4,584) | (3,932) | (3,320) |
| Proceeds from common stock issuances | 1,440 | 1,037 | 838 |
| Repayments of long-term debt | (3,150) | (1,750) | (2,600) |
| Proceeds from (repayments of) short-term borrowings, net | 872 | 300 | (201) |
| Proceeds from issuance of long-term debt | 4,864 | 5,444 | 6,935 |
| Customer funds administered | 1,677 | 13 | (131) |
| Other, net | (459) | (1,237) | (1,386) |
| Cash flows used for financing activities | (3,590) | (5,625) | (4,365) |
| Effect of exchange rate changes on cash and cash equivalents | (116) | (20) | (78) |
| Increase (decrease) in cash and cash equivalents | 5,936 | 119 | (1,115) |
| Cash and cash equivalents, beginning of period | 10,985 | 10,866 | |
| Cash and cash equivalents, end of period | 16,921 | 10,985 | 10,866 |
| Supplemental cash flow disclosures | |||
| Cash paid for interest | 1,704 | 1,627 | 1,410 |
| Cash paid for income taxes | 4,935 | 3,542 | 3,257 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
UNITEDHEALTH GROUP INC | ||
Ticker: UNH Fiscal Year: 2020 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2020 10-K (Filed: Mar 1, 2021) | ||
| (In Millions) | ||
| As of | As of | |
| Dec 31, 2020 | Dec 31, 2019 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $ 16,921 | 10,985 |
| Short-term investments | 2,860 | 3,260 |
| Accounts receivable, net of allowances of $990 and $519 | 12,870 | 11,822 |
| Other current receivables, net of allowances of $1,047 and $859 | 12,534 | 9,640 |
| Assets under management | 4,076 | 3,076 |
| Prepaid expenses and other current assets | 4,457 | 3,851 |
| Total current assets | 53,718 | 42,634 |
| Long-term investments | 41,242 | 37,209 |
| Property, equipment and capitalized software, net of accumulated depreciation and amortization of $5,230 and $4,995 | 8,626 | 8,704 |
| Goodwill | 71,337 | 65,659 |
| Other intangible assets, net of accumulated amortization of $5,455 and $5,072 | 10,856 | 10,349 |
| Other assets | 11,510 | 9,334 |
| Total assets | 197,289 | 173,889 |
| Liabilities, redeemable noncontrolling interests and equity | ||
| Current liabilities: | ||
| Medical costs payable | 21,872 | 21,690 |
| Accounts payable and accrued liabilities | 22,495 | 19,005 |
| Short-term borrowings and current maturities of long-term debt | 4,819 | 3,870 |
| Unearned revenues | 2,842 | 2,622 |
| Other current liabilities | 20,392 | 14,595 |
| Total current liabilities | 72,420 | 61,782 |
| Long-term debt, less current maturities | 38,648 | 36,808 |
| Deferred Income Taxes | 3,367 | 2,993 |
| Other liabilities | 12,315 | 10,144 |
| Total liabilities | 126,750 | 111,727 |
| Commitments and contingencies (Note 12) | ||
| Redeemable noncontrolling interests | 2,211 | 1,726 |
| Equity: | ||
| Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding | 0 | 0 |
| Common stock, $0.01 par value - 3,000 shares authorized; 946 and 948 issued and outstanding | 10 | 9 |
| Additional paid-in capital | 0 | 7 |
| Retained earnings | 69,295 | 61,178 |
| Accumulated other comprehensive loss | (3,814) | (3,578) |
| Nonredeemable noncontrolling interests | 2,837 | 2,820 |
| Total equity | 68,328 | 60,436 |
| Total liabilities, redeemable noncontrolling interests and equity | 197,289 | 173,889 |
| Preferred stock, par value | 0.001 | 0.001 |
| Preferred stock, shares authorized | 10 | 10 |
| Preferred stock, shares issued | 0 | 0 |
| Preferred stock, shares outstanding | 0 | 0 |
| Common stock, par value | 0.010 | 0.010 |
| Common stock, shares authorized | 3,000 | 3,000 |
| Common stock, shares issued | 946 | 948 |
| Common Stock, Shares, Outstanding | 946 | 948 |
| External Links | |
| UNITEDHEALTH GROUP INC (UNH) Fiscal Year 2020 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |